Leukocyte adhesion molecules in transplantation

American Journal of Medicine

Volumn 107, Issue 2, 1999, Pages 157-165

  Rabb, Hamid ^a   Bonventre, Joseph V ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; VASCULAR CELL ADHESION MOLECULE 1;

ANTIGEN PRESENTING CELL; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; KIDNEY ALLOGRAFT REJECTION; MALE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; XENOGRAFT;

EID: 0032866816     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)00199-0     Document Type: Article

References (81)

1. Hynes R.O. Integrins versatility, modulation, and signaling in cell adhesion . Cell. 69:1992;11-25.
2. Lasky L.A. Selectins interpreters of cell-specific carbohydrate information during inflammation . Science. 258:1992;964-969.
3. Luscinskas F.W., Ding H., Lichtman A.H. P-selectin and vascular cell adhesion molecule 1 mediate rolling and arrest, respectively, of CD4+ T lymphocytes on tumor necrosis factor alpha-activated vascular endothelium under flow. J Exp Med. 181:1995;1179-1186.
4. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigration the multistep paradigm . Cell. 76:1994;1-14.
5. Springer T.A. Adhesion receptors of the immune system. Nature. 346:1990;425-434.
6. Hemler M.E. VLA proteins in the integrin family structures, functions, and their role on leukocytes . Annu Rev Immunol. 8:1990;365-400.
7. del Pozo M.A., Sanchez-Mateos P., Sanchez-Madrid F. Cellular polarization induced by chemokines a mechanism for leukocyte recruitment? Immunol Today. 17:1996;127-131.
8. Bianchi E., Bender J.R., Blasi F., Pardi R. Through and beyond the wall late steps in leukocyte transendothelial migration . Immunol Today. 18:1997;586-591.
9. Muller W.A. The role of PECAM-1 (CD31) in leukocyte emigration studies in vitro and in vivo . J Leukoc Biol. 57:1995;523-528.
10. Maiti A., Maki G., Johnson P. TNF-alpha induction of CD44-mediated leukocyte adhesion by sulfation. Science. 282:1998;941-943.
11. Briscoe D.M., Alexander S.I., Lichtman A.H. Interactions between T lymphocytes and endothelial cells in allograft rejection. Curr Opin Immunol. 10:1998;525-531.
12. Perkins D.L., Carpenter C.B. Immunobiology of transplantation. Brenner B.M. The Kidney. 1996;2576-2601 WB Saunders Company, Philadelphia.
13. Le Mauff B., Hourmant M., Rougier J.P., et al. Effect of anti-LFA1 (CD11a) monoclonal antibodies in acute rejection in human kidney transplantation. Transplantation. 52:1991;291-296.
14. Hourmant M., Le Mauff B., Le Meur Y., et al. Administration of an anti-CD11a monoclonal antibody in recipients of kidney transplantation. A pilot study. Transplantation. 58:1994;377-379.
15. Haug C.E., Colvin R.B., Delmonico F.L., et al. A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation. 1993;766-773.
16. Cosimi A.B., Conti D., Delmonico F.L., et al. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. J Immunol. 144:1990;4604-4612.
17. Gorczynski R.M., Chen Z., Zeng H., Fu X.M. A role for persisting antigen, antigen presentation, and ICAM-1 in increased renal graft survival after oral or portal vein donor-specific immunization. Transplantation. 66:1998;339-349.
18. Kanagawa K., Ishikura H., Ishizu A., et al. Strain combination-dependent genesis of necrotizing arteritis in anti-ICAM-1 antibody-perfused renal allografts in the rat. Pathol Internat. 45:1995;196-201.
19. Isobe M., Yagita H., Okumura K., Ihara A. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science. 255:1992;1125-1127.
20. Kobayashi H., Miyano T., Yamataka A., et al. Prolongation or rat cardiac allograft survival by a monoclonal antibody anti-rat intercellular adhesion molecule 1 . Cardiovasc Surg. 1:1993;577-582.
21. Stepkowski S.M., Tu Y., Bennett C.F. Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonuclear alone or in combination with other immunosuppressive modalities. J Immunol. 153:1994;5336-5346.
22. Nakakura E.K., McCabe S.M., Zheng B., et al. Potent and effective proliferation of anti-LFA-1 monoclonal antibody monotherapy of non-primarily vascularized heart allograft survival in mice without T cell depletion. Transplantation. 55:1993;412-417.
23. Orosz C.G., Ohye R.G., Pelletier R.P., et al. Treatment with anti-vascular adhesion molecule 1 monoclonal antibody induces long-term murine corneal allograft acceptance. Transplantation. 56:1993;453-460.
24. Isobe M., Suzuki J., Yagita H., et al. Immunosuppression to cardiac allograft and soluble antigens by anti-vascular cellular adhesion molecule-1 and very late antigen-4 monoclonal antibodies. J Immunol. 153:1994;5810-5815.
25. Kameoka H., Ishibashi M., Tamatani T., et al. The immunosuppressive action of anti-CD18 monoclonal antibody in rat heterotopic heart allotransplantation. Transplantation. 55:1993;665-667.
26. Paul L.C., Davidoff A., Benediktsson H., Issekutz T.B. The efficacy of LFA-1 and VLA-4 antibody treatment in rat vascularized cardiac allograft rejection. Transplantation. 55:1993;1196-1199.
27. Sadahiro M., McDonald T.O., Allen M.D. Reduction in cellular and vascular rejection by blocking leukocyte adhesion molecule receptors. Am J Pathol. 142:1993;675-683.
28. Nishihara M., Gotoh M., Ohzato H., et al. Awareness of donor alloantigens in antiadhesion therapy induces antigen-specific unresponsiveness to islet allografts. Transplantation. 64:1997;965-970.
29. Hori J., Isobe M., Yamagami S., Mizuochi T., Tsuru T. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice. Exp Eye Res. 65:1997;89-98.
30. Molossi S., Elices M., Arrhenius T., Diaz R., Coulber C., Rabinovitch M. Blockade of very late antigen-4 integrin binding to fibronectin with connecting segment-1 peptide reduces accelerated coronary arteriopathy in rabbit cardiac allografts. J Clin Invest. 95:1995;2601-2610.
31. Romer K., Herwartz C., Steinhoff G., Steinmann J. Lack of in vitro synergy of clinically used antibodies specific for ICAM-1 and LFA-1. Transpl Immunol. 5:1997;162-164.
32. Brandt M., Steinmann J., Steinhoff G., Haverich A. Treatment with monoclonal antibodies to ICAM-1 and LFA-1 in rat heart allograft rejection. Transpl Int. 10:1997;141-144.
33. Schowengerdt K.O., Zhu J.Y., Stepkowski S.M., Tu Y., Entman M.L., Ballantyne C.M. Cardiac allograft survival in mice deficient in intercellular adhesion molecule-1. Circulation. 92:1995;82-87.
34. Omura T., Ishikura H., Nakajima Y., et al. Accelerated rejection of allografted rat liver perfused with anti-ICAM-1 monoclonal antibody. Immunobiology. 186:1992;241-245.
35. Hourmant M., Bedrossian J., Durand D., et al. A randomized multicenter trial comparing leukocyte function-associated antigen-1 monoclonal antibody with rabbit antithymocyte globulin as induction treatment in first kidney transplantations. Transplantation. 62:1996;1565-1570.
36. Uff C.R., Reid S.D., Wood R.F., Pockley A.G. CD44 expression in rejecting rat small bowel allografts. Transplantation. 60:1995;985-989.
37. Briscoe D.M., Ganz P., Alexander S.I., et al. The problem of chronic rejection influence of leukocyte-endothelial interactions . Kidney Int. 51:(suppl 58):1997;S22-S27.
38. Foegh M.L. Chronic rejection graft arteriosclerosis . Transplant Proc. 22:1990;119-122.
39. Salomon R.N., Hughes C.C., Schoen F.J., Payne D.D., Pober J.S., Libby P. Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. Am J Pathol. 138:1991;791-798.
40. Hancock W.H., Whitley W.D., Tullius S.G., et al. Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts. Transplantation. 56:1993;643-650.
41. Davis SF, Baum MA, Anderson TJ, et al. Chronic low grade rejection and VCAM-1 induction on serial endomyocardial biopsies predicts transplant coronary artery disease. Circulation 1995;92:I-39. Abstract.
42. Polverini P.J. Cellular adhesion molecules. Newly identified mediators of angiogenesis. Am J Pathol. 148:1996;1023-1029.
43. Bonventre J.V., Weinberg J.M. Kidney preservation ex vivo for transplantation. Annu Rev Med. 43:1992;523-553.
44. Terasaki P.I., Cecka J.M., Gjertson D.W., Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med. 333:1995;333-336.
45. Rabb H., O'Meara Y.M., Maderna P., Coleman P., Brady H.R. Leukocytes, cell adhesion molecules and ischemic acute renal failure. Kidney Int. 51:1997;1463-1468.
46. Thadhani R., Pascual M., Bonventre J.V. Acute renal failure. N Engl J Med. 334:1996;1448-1460.
47. Yoshida N., Granger D.N., Anderson D.C., Rothlein R., Lane C., Kvietys P.R. Anoxia/reoxygenation-induced neutrophil adherence to cultured endothelial cells. Am J Physiol. 262:1992;H1891-H1898.
48. Thornton M.A., Winn R., Alpers C.E., Zager R.A. An evaluation of the neutrophil as a mediator of in vivo renal ischemic-reperfusion injury. Am J Pathol. 135:1989;509-515.
49. Brady H.R. Leukocyte adhesion molecules and kidney diseases. Kidney Int. 45:1994;1285-1300.
50. Kelly K.J., Williams W.W., Colvin R.B., Bonventre J.V. Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci USA. 91:1994;812-816.
51. Rabb H, Mendiola CC, Saba SR, et al. Antibodies to ICAM-1 protect kidneys in severe ischemic reperfusion injury. Biochem Biophys Res Commun 1995;211:67-73.
52. Linus S.L., Whittenburg D., Parsons P.E., Repine J.E. Ischemia increases neutrophil retention and worsens acute renal failure role of oxygen metabolites and ICAM-1 . Kidney Int. 48:1995;1584-1591.
53. Haller H., Dragun D., Miethke A., et al. Antisense oligonucleotides for ICAM-1 attenuate reperfusion injury and renal failure in the rat. Kidney Int. 50:1996;473-480.
54. Rabb H., Mendiola C.C., Dietz J., et al. Role of CD11a and CD11b in ischemic acute renal failure in rats. Am J Physiol. 267:1994;F1052-F1058.
55. Rabb H, Mendiola C, Saba SR, et al. Antibodies to P-selectin and ICAM-1 protect kidneys from ischemic-reperfusion injury. J Am Soc Nephrol 1994;5:907A. Abstract.
56. Takada M., Nadeau K.C., Shaw G.D., Marquette K.A., Tilney N.L. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest. 99:1997;2682-2690.
57. Dragun D., Tullius S.G., Park J.K., et al. ICAM-1 antisense oligodesoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation. Kidney Int. 54:1998;590-602.
58. Rabb H., Ramirez G., Saba S.R., et al. Renal ischemic-reperfusion injury in L-selectin deficient mice. Am J Physiol. 271:1996;F408-F413.
59. Kelly K.J., Williams W.W., Colvin R.B., et al. Intercellular adhesion molecule-1-deficient mice are protected against ischemic renal injury. J Clin Invest. 97:1996;1056-1063.
60. Chiao H., Kohda Y., McLeroy P., Craig L., Linas S., Star R.A. Alpha-melanocyte-stimulating hormone inhibits renal injury in the absence of neutrophils. Kidney Int. 54:1998;765-774.
61. Rabb H, Haq M, Saba S, Liu Z, Lowe J. Fucosyl transferase IV mediates renal inflammation and dysfunction from ischemia reperfusion. J Am Soc Nephrol 1998;9:589A. Abstract.
62. Scoazec J.Y., Durand F., Degott C., et al. Expression of cytokine-dependent adhesion molecules in postreperfusion biopsy specimens of liver allografts. Gastroenterology. 107:1994;1094-1102.
63. Byrne J.G., Smith W.J., Murphy M.P., Couper G.S., Appleyard R.F., Cohn L.H. Complete prevention of myocardial stunning, contracture, low-reflow, and edema after heart transplantation by blocking neutrophil adhesion molecules during reperfusion. J Thorac Cardiovasc Surg. 104:1992;1589-1596.
64. Koo D.D., Welsh K.I., Roake J.A., Morris P.J., Fuggle S.V. Ischemia/reperfusion injury in human kidney transplantation an immunohistochemical analysis of changes after reperfusion . Am J Pathol. 153:1998;557-566.
65. Kupiec-Weglinski J.W., Paul L.C. Cellular and extracellular matrix adhesion molecules in organ transplantation. Paul L.C., Issekutz T.B. Adhesion Molecules in Health and Disease. 1997;679-708 Marcel Dekker, New York.
66. Fuggle S.V., Sanderson J.B., Gray D.W., Richardson A., Morris P.J. Variation in expression of endothelial adhesion molecules in pretransplant and transplanted kidneys correlation with intragraft events . Transplantation. 55:1993;117-123.
67. Frishberg Y., Meyers C.M., Kelly C.J. Cyclosporine A regulates T cell-epithelial cell adhesion by altering LFA-1 and ICAM-1 expression. Kidney Int. 50:1996;45-53.
68. Gearing A.J., Newman W. Circulating adhesion molecules in disease. Immunol Today. 14:1993;506-512.
69. Rabb H., Calderon E., Bittle P., Ramirez G. Effects of hemodialysis on soluble ICAM-1 and VCAM-1. Am J Kidney Dis. 27:1996;239-243.
70. Bechtel U., Scheuer R., Landgraf R., Konig A., Feucht H.E. Assessment of soluble adhesion molecules (sICAM-1, aVCAM-1, sELAM-1) and complement cleavage products (sC4d, sC5b-9) in urine clinical monitoring of renal allograft recipients . Transplantation. 58:1994;905-911.
71. Bacchi C.E., Marsh C.L., Perkins J.D., et al. Expression of vascular cell adhesion molecule (VCAM-1) in liver and pancreas allograft rejection. Am J Pathol. 142:1993;579-591.
72. Corey H.E., Alfonso F., Hamele-Bena D., et al. Urine cytology and the diagnosis of renal allograft rejection. II. Studies using immunostaining. Acta Cytol. 41:1997;1742-1746.
73. Zeng Y., Torres M.A., Thistlethwaite J.R. Jr, Montag A., Bluestone J.A. Prolongation of human pancreatic islet xenografts by pretreatment of islets with anti-human ICAM-1 monoclonal antibody. Transplant Proc. 26:1994;1120-1120.
74. Ohta Y., Gotoh M., Ohzato H., et al. Direct antigen presentation through binding of donor intercellular adhesion molecule-1 to recipient lymphocyte function-associated antigen-1 molecules in xenograft rejection. Transplantation. 65:1998;1094-1100.
75. Brandt M., Derner G., Boeke K., Phillips M.L., Steinhoff G., Haverich A. Anti-rejection prophylaxis by blocking selectin dependent cell adhesion after rat allogeneic and zenogeneic lung transplantation. Eur J Cardio-Thorac Surg. 12:1997;781-786.
76. Horimoto H., Nozawa M., Kokudo N., et al. Immunoregulation via adhesion molecules in allogenic and zenogenic hepatocyte transplantation to Nagase's analbuminemic rats. Cell Transplant. 6:1997;535-536.
77. Sandberg J.O., Korsgren O. Islet allo- and zenotransplantation in normal, intercellular adhesion molecule-1-deficient, and P selectin-deficient mice. Transplantation. 64:1997;584-589.
78. Yamagami S., Isobe M., Yamagami H., Hori J., Tsuru T. Mechanism of concordant corneal xenograft rejection in mice synergistic effects of anti-leukocyte function-associated antigen-1 monoclonal antibody and FK506 . Transplantation. 64:1997;42-48.
79. Jorgensen C., Couret I., Canovas F., et al. Mononuclear cell retention in rheumatoid synovial tissue engrafted in severe combined immunodeficient (SCID) mice is up-regulated by tumour necrosis factor-alpha (TNF-alpha) and mediated through intercellular adhesion molecule-1 (ICAM-1). Clin Exper Immunol. 106:1996;20-25.
80. Coughlan A.F., Berndt M.C., Dunlop L.C., Hancock W.W. In vivo studies of P-selectin and platelet activating factor during endotoxemia, accelerated allograft rejection, and discordant xenograft rejection. Transplant Proc. 25:1993;2930-2931.
81. Simon A.R., Warrens A.N., Yazzie N.P., Seebach J.D., Sachs D.H., Sykes M. Cross-species interaction of porcine and human integrins with their respective ligands implications for zenogeneic tolerance induction . Transplantation. 66:1998;385-394.